94 related articles for article (PubMed ID: 33393080)
21. Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-deficient mice.
Graf C; Niwa S; Müller M; Kinzel B; Bornancin F
Biochem Biophys Res Commun; 2008 Aug; 373(1):159-63. PubMed ID: 18555012
[TBL] [Abstract][Full Text] [Related]
22. CERKL mutations and associated phenotypes in seven Spanish families with autosomal recessive retinitis pigmentosa.
Avila-Fernandez A; Riveiro-Alvarez R; Vallespin E; Wilke R; Tapias I; Cantalapiedra D; Aguirre-Lamban J; Gimenez A; Trujillo-Tiebas MJ; Ayuso C
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2709-13. PubMed ID: 18515597
[TBL] [Abstract][Full Text] [Related]
23. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.
Zhang L; Qin H; Wu Z; Chen W; Zhang G
Int J Dermatol; 2018 Oct; 57(10):1208-1217. PubMed ID: 30105812
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of CERKL Protects Retinal Pigment Epithelium Mitochondria from Oxidative Stress Effects.
García-Arroyo R; Gavaldà-Navarro A; Villarroya F; Marfany G; Mirra S
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943121
[TBL] [Abstract][Full Text] [Related]
26. Genetic and Clinical Findings in an Ethnically Diverse Cohort with Retinitis Pigmentosa Associated with Pathogenic Variants in CERKL.
Downes SM; Nguyen T; Tai V; Broadgate S; Shah M; Al-Khuzaei S; MacLaren RE; Shanks M; Clouston P; Halford S
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33322828
[TBL] [Abstract][Full Text] [Related]
27. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
Lu D; Sun L; Li Z; Mu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
[TBL] [Abstract][Full Text] [Related]
28. High transcriptional complexity of the retinitis pigmentosa CERKL gene in human and mouse.
Garanto A; Riera M; Pomares E; Permanyer J; de Castro-Miró M; Sava F; Abril JF; Marfany G; Gonzàlez-Duarte R
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5202-14. PubMed ID: 21508105
[TBL] [Abstract][Full Text] [Related]
29. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
Xia Y; Chang X; Lian S; Zhu W
J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
[TBL] [Abstract][Full Text] [Related]
30. Targeted knockdown of Cerkl, a retinal dystrophy gene, causes mild affectation of the retinal ganglion cell layer.
Garanto A; Vicente-Tejedor J; Riera M; de la Villa P; Gonzàlez-Duarte R; Blanco R; Marfany G
Biochim Biophys Acta; 2012 Aug; 1822(8):1258-69. PubMed ID: 22549043
[TBL] [Abstract][Full Text] [Related]
31. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
[TBL] [Abstract][Full Text] [Related]
33. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
34. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
Zuo S; Li X; Bao W; Li S
Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
[TBL] [Abstract][Full Text] [Related]
35. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
Deng X; Zhen P; Niu X; Dai Y; Wang Y; Zhou M
J Dermatol Sci; 2020 Oct; 100(1):67-74. PubMed ID: 32951990
[TBL] [Abstract][Full Text] [Related]
36. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
37. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
38. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.
Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z
Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873
[TBL] [Abstract][Full Text] [Related]
40. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
Fan Z; Qin J; Wang D; Geng S
J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
